BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mieli-Vergani G, Vergani D. Autoimmune paediatric liver disease. World J Gastroenterol 2008; 14(21): 3360-3367 [PMID: 18528933 DOI: 10.3748/wjg.14.3360] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Bluth MH, Kohlhoff S, Norowitz KB, Silverberg JI, Chice S, Nowakowski M, Durkin HG, Smith-Norowitz TA. Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case report. Int J Med Sci 2009;6:177-83. [PMID: 19584951 DOI: 10.7150/ijms.6.177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun. 2010;34:J300-J306. [PMID: 20036105 DOI: 10.1016/j.jaut.2009.12.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
3 Noble-jamieson G, Heuschkel R, Torrente F, Hadzic N, Zilbauer M. Colitis-associated sclerosing cholangitis in children: A single centre experience. Journal of Crohn's and Colitis 2013;7:e414-8. [DOI: 10.1016/j.crohns.2013.01.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Lian JS, Liu W, Hao SR, Chen DY, Wang YY, Yang JL, Jia HY, Huang JR. A serum metabolomic analysis for diagnosis and biomarker discovery of primary biliary cirrhosis and autoimmune hepatitis. Hepatobiliary Pancreat Dis Int 2015;14:413-21. [PMID: 26256087 DOI: 10.1016/s1499-3872(15)60393-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
5 Alsayed MAL, Elbeah SM, El-Desoky MM, Elziny SM, Megahed A. Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis. Pediatr Gastroenterol Hepatol Nutr 2020;23:63-71. [PMID: 31988876 DOI: 10.5223/pghn.2020.23.1.63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kim DK, Yoon H, Han K, Kim J, Lee MJ, Kim S, Koh H, Han SJ, Shin HJ. Effect of different driver power amplitudes on liver stiffness measurement in pediatric liver MR elastography. Abdom Radiol (NY) 2021;46:4729-35. [PMID: 34216244 DOI: 10.1007/s00261-021-03197-3] [Reference Citation Analysis]
7 Alisi A, de Vito R, Monti L, Nobili V. Liver fibrosis in paediatric liver diseases. Best Pract Res Clin Gastroenterol. 2011;25:259-268. [PMID: 21497743 DOI: 10.1016/j.bpg.2011.02.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
8 Smyk DS, Bogdanos DP, Kriese S, Billinis C, Burroughs AK, Rigopoulou EI. Urinary tract infection as a risk factor for autoimmune liver disease: From bench to bedside. Clinics and Research in Hepatology and Gastroenterology 2012;36:110-21. [DOI: 10.1016/j.clinre.2011.07.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
9 Mackay IR. Clustering and commonalities among autoimmune diseases. Journal of Autoimmunity 2009;33:170-7. [DOI: 10.1016/j.jaut.2009.09.006] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 5.9] [Reference Citation Analysis]
10 Nobili V, Monti L, Alisi A, Zupone CL, Pietrobattista A, Tomà P. Transient elastography for assessment of fibrosis in paediatric liver disease. Pediatr Radiol 2011;41:1232-8. [DOI: 10.1007/s00247-011-2143-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
11 Krones E, Graziadei I, Trauner M, Fickert P. Evolving concepts in primary sclerosing cholangitis. Liver International 2011. [DOI: 10.1111/j.1478-3231.2011.02607.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
12 Lohse AW, Mieli-Vergani G. Autoimmune hepatitis. J Hepatol. 2011;55:171-182. [PMID: 21167232 DOI: 10.1016/j.jhep.2010.12.012] [Cited by in Crossref: 121] [Cited by in F6Publishing: 89] [Article Influence: 11.0] [Reference Citation Analysis]
13 Cuarterolo ML, Ciocca ME, López SI, de Dávila MT, Álvarez F. Immunosuppressive Therapy Allows Recovery From Liver Failure in Children With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 2011;9:145-149.e1. [DOI: 10.1016/j.cgh.2010.10.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
14 Trivedi PJ, Chapman RW. PSC, AIH and overlap syndrome in inflammatory bowel disease. Clin Res Hepatol Gastroenterol. 2012;36:420-436. [PMID: 22306055 DOI: 10.1016/j.clinre.2011.10.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
15 Serai SD, Yin M, Wang H, Ehman RL, Podberesky DJ. Cross-vendor validation of liver magnetic resonance elastography. Abdom Imaging. 2015;40:789-794. [PMID: 25476489 DOI: 10.1007/s00261-014-0282-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
16 Greene MT, Whitington PF. Outcomes in pediatric autoimmune hepatitis. Curr Gastroenterol Rep. 2009;11:248-251. [PMID: 19463226 DOI: 10.1007/s11894-009-0038-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Lohse AW. Recognizing autoimmune hepatitis: scores help, but no more. J Hepatol. 2011;54:193-194. [PMID: 21093949 DOI: 10.1016/j.jhep.2010.07.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
18 Knight C, Murray KF. Hepatobiliary associations with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2009;3:681-691. [PMID: 19929587 DOI: 10.1586/egh.09.53] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
19 Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, Mazariegos GV. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014;60:362-398. [PMID: 24782219 DOI: 10.1002/hep.27191] [Cited by in Crossref: 101] [Cited by in F6Publishing: 68] [Article Influence: 14.4] [Reference Citation Analysis]
20 Gargouri L, Mnif L, Safi F, Turki F, Majdoub I, Maalej B, Bahri I, Mnif H, Boudawara T, Tahri N, Mahfoudh A. Type 2 autoimmune hepatitis overlapping with primary sclerosing cholangitis in a 10-year-old boy. Arch Pediatr. 2013;20:1325-1328. [PMID: 24182664 DOI: 10.1016/j.arcped.2013.09.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Serai SD, Towbin AJ, Podberesky DJ. Pediatric liver MR elastography. Dig Dis Sci. 2012;57:2713-2719. [PMID: 22569825 DOI: 10.1007/s10620-012-2196-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
22 Hovinga IC, Stam ED, Mearin ML, Mul D. A girl with type 1 diabetes and a yellowish appearance. BMJ Case Rep 2010;2010:bcr0420102899. [PMID: 22797478 DOI: 10.1136/bcr.04.2010.2899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Pawłowska M, Halota W. Acute liver failure caused by concurrent autoimmune hepatitis and hepatitis B in a 16-year old girl. World J Hepatol. 2010;2:392-394. [PMID: 21160949 DOI: 10.4254/wjh.v2.i10.392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Rigopoulou EI, Smyk DS, Matthews CE, Billinis C, Burroughs AK, Lenzi M, Bogdanos DP. Epstein-barr virus as a trigger of autoimmune liver diseases. Adv Virol. 2012;2012:987471. [PMID: 22693505 DOI: 10.1155/2012/987471] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
25 Flores-calderón J, Morán-villota S, Ramón-garcía G, González-romano B, del Carmen Bojórquez-ramos M, Cerdán-silva L, Hernández-frías P. Non-invasive markers of liver fibrosis in chronic liver disease in a group of Mexican children. A multicenter study. Annals of Hepatology 2012;11:364-8. [DOI: 10.1016/s1665-2681(19)30933-0] [Cited by in Crossref: 9] [Article Influence: 1.0] [Reference Citation Analysis]
26 Invernizzi P, Alessio MG, Smyk DS, Lleo A, Sonzogni A, Fabris L, Candusso M, Bogdanos DP, Iorio R, Torre G. Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature. BMC Gastroenterol 2012;12:92. [PMID: 22816667 DOI: 10.1186/1471-230X-12-92] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
27 Fallatah HI, Akbar HO. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy. Expert Rev Gastroenterol Hepatol. 2011;5:517-522. [PMID: 21780898 DOI: 10.1586/egh.11.45] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
28 Kumari N, Kathuria R, Srivastav A, Krishnani N, Poddar U, Yachha SK. Significance of histopathological features in differentiating autoimmune liver disease from nonautoimmune chronic liver disease in children. Eur J Gastroenterol Hepatol. 2013;25:333-337. [PMID: 23085577 DOI: 10.1097/meg.0b013e32835a68a1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
29 Roberts SK, Lim R, Strasser S, Nicoll A, Gazzola A, Mitchell J, Siow W, Khoo T, Hamarneh Z, Weltman M, Gow P, Janko N, Tse E, Mishra G, Cheng EH, Levy M, Cheng W, Sood S, Skoien R, Mitchell J, Zekry A, George J, MacQuillan G, Wigg A, Stuart K, Sievert W, McCaughan G; ALA Clinical Research Network. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy. Clin Gastroenterol Hepatol 2018;16:268-77. [PMID: 29050991 DOI: 10.1016/j.cgh.2017.09.063] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
30 Jarasvaraparn C, Imran H, Siddiqui A, Wilson F, Gremse DA. Association of autoimmune hepatitis type 1 in a child with Evans syndrome. World J Hepatol 2017;9:1008-12. [PMID: 28878866 DOI: 10.4254/wjh.v9.i23.1008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
31 Domingos JP, Garrido C, Moreira Silva H, Monteiro C, Silva ES, Figueiroa S, Carrilho IC. Chronic inflammatory demyelinating polyneuropathy associated with autoimmune hepatitis. Pediatr Neurol 2014;51:e13-4. [PMID: 25160557 DOI: 10.1016/j.pediatrneurol.2014.04.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
32 Lee CZ, Peng SS, Lee CS, Chen HL, Ni YH, Chang MH, Wu JF. Transient elastography correlated with diffusion-weighted magnetic resonance imaging and cholestatic complications. J Formos Med Assoc 2019;118:1522-7. [PMID: 30621960 DOI: 10.1016/j.jfma.2018.12.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 López SI, Ciocca M, Oleastro M, Cuarterolo ML, Rocca A, de Dávila MT, Roy A, Fernández MC, Nievas E, Bosaleh A, Torgerson TR, Ruiz JA. Autoimmune Hepatitis Type 2 in a Child With IPEX Syndrome. Journal of Pediatric Gastroenterology & Nutrition 2011;53:690-3. [DOI: 10.1097/mpg.0b013e3182250651] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
34 Mullin S, Rabah R, Malas S, Bitar A. Autoimmune Hepatitis Type 2 Associated With Positive Antimitochondrial Antibodies: An Overlap Syndrome? Clin Pediatr (Phila) 2016;55:479-82. [DOI: 10.1177/0009922815588980] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
35 Díaz-Ramírez GS, Marín-Zuluaga JI, Donado-Gómez JH, Muñoz-Maya O, Santos-Sánchez Ó, Restrepo-Gutiérrez JC. Characterization of patients with autoimmune hepatitis at an university hospital in Medellín-Colombia: cohort study. Gastroenterol Hepatol 2018;41:87-96. [PMID: 29126693 DOI: 10.1016/j.gastrohep.2017.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
36 Cho JM, Kim KM, Oh SH, Lee YJ, Rhee KW, Yu E. De novo autoimmune hepatitis in Korean children after liver transplantation: a single institution’s experience. Transplant Proc. 2011;43:2394-2396. [PMID: 21839275 DOI: 10.1016/j.transproceed.2011.05.030] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
37 Gutierrez MJ, Gilson J, Zacharias J, Ishmael F, Bingham CA. Childhood Polyarthritis As Early Manifestation of Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy Syndrome. Front Immunol 2017;8:377. [PMID: 28458664 DOI: 10.3389/fimmu.2017.00377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Chai PF, Lee WS, Brown RM, Mcpartland JL, Foster K, Mckiernan PJ, Kelly DA. Childhood Autoimmune Liver Disease: Indications and Outcome of Liver Transplantation. Journal of Pediatric Gastroenterology & Nutrition 2010;50:295-302. [DOI: 10.1097/mpg.0b013e3181bf0ef7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
39 Haerskjold A, Linder M, Henriksen L, Thomsen SF, Kieler H, Ravn H, Stensballe LG. Palivizumab Exposure and the Risk of Autoimmune Disease: A Cross-National Cohort Study. Paediatr Drugs 2016;18:435-41. [PMID: 27665287 DOI: 10.1007/s40272-016-0191-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
40 Moy L, Levine J. Autoimmune hepatitis: a classic autoimmune liver disease. Curr Probl Pediatr Adolesc Health Care. 2014;44:341-346. [PMID: 25466500 DOI: 10.1016/j.cppeds.2014.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
41 Eren E, Özkan TB, Çakır ED, Sağlam H, Tarım Ö. Acquired generalized lipodystrophy associated with autoimmune hepatitis and low serum C4 level. J Clin Res Pediatr Endocrinol 2010;2:39-42. [PMID: 21274335 DOI: 10.4274/jcrpe.v2i1.39] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
42 Fallatah HI, Akbar HO. Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview. Autoimmune Dis. 2012;2012:312817. [PMID: 23304455 DOI: 10.1155/2012/312817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
43 Abu Faddan NH, Abdel-baky L, Aly SA, Rashed HG. Clinico-laboratory study on children with auto-immune hepatitis in Upper Egypt. Arab Journal of Gastroenterology 2011;12:178-83. [DOI: 10.1016/j.ajg.2011.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
44 Girard M, Franchi-abella S, Lacaille F, Debray D. Specificities of sclerosing cholangitis in childhood. Clinics and Research in Hepatology and Gastroenterology 2012;36:530-5. [DOI: 10.1016/j.clinre.2012.04.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
45 Deneau M, Book LS, Guthery SL, Jensen MK. Outcome after Discontinuation of Immunosuppression in Children with Autoimmune Hepatitis: A Population-Based Study. The Journal of Pediatrics 2014;164:714-719.e2. [DOI: 10.1016/j.jpeds.2013.12.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
46 Karakoyun M, Ecevit CO, Kilicoglu E, Aydogdu S, Yagci RV, Ozgenc F. Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience. Eur J Gastroenterol Hepatol. 2016;28:927-930. [PMID: 27254777 DOI: 10.1097/meg.0000000000000648] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]